Published in Neurology on April 22, 1999
Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet (2008) 3.08
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis (2012) 1.66
Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol (2008) 1.54
Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord (2015) 1.52
PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet (2006) 1.44
Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. Am J Pathol (2009) 1.08
Neuropathy target esterase is required for adult vertebrate axon maintenance. J Neurosci (2009) 1.01
Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6. Hum Mol Genet (2012) 0.94
Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site. Acta Neuropathol Commun (2013) 0.87
PLA2G6-associated Dystonia-Parkinsonism: Case Report and Literature Review. Tremor Other Hyperkinet Mov (N Y) (2015) 0.85
Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation. PLoS One (2011) 0.81
Expression of PLA2G6 in human fetal development: Implications for infantile neuroaxonal dystrophy. Brain Res Bull (2010) 0.79
Low vision due to cerebral visual impairment: differentiating between acquired and genetic causes. BMC Ophthalmol (2014) 0.78
iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology. Neurochem Res (2014) 0.76
Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation. Rare Dis (2016) 0.75
Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review. Exp Ther Med (2016) 0.75
Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis. Neuroradiology (2016) 0.75
Neurotoxicity of a prion protein fragment. Nature (1993) 3.38
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett (1989) 2.69
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta (2004) 2.52
Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology (1999) 2.33
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett (1988) 2.26
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A (1996) 1.94
Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci (2004) 1.92
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology (2011) 1.91
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology (1999) 1.84
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand (1992) 1.76
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem (2000) 1.71
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell (1994) 1.69
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
Superficial siderosis of the CNS: MR diagnosis and clinical findings. AJNR Am J Neuroradiol (1993) 1.65
Prion protein amyloidosis. Brain Pathol (1996) 1.64
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology (2010) 1.59
Spontaneous low cerebrospinal pressure: a mini review. Neurol Sci (2004) 1.53
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol (1999) 1.49
Progressive dystonia symptomatic of juvenile GM2 gangliosidosis. Mov Disord (1992) 1.46
Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol (2014) 1.39
An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39
Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology (1999) 1.37
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett (1989) 1.35
Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol (2008) 1.35
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation (1998) 1.33
The association of GRB 060218 with a supernova and the evolution of the shock wave. Nature (2006) 1.32
A short gamma-ray burst apparently associated with an elliptical galaxy at redshift z = 0.225. Nature (2005) 1.32
Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology (2003) 1.31
Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport (1993) 1.28
Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol (1995) 1.25
The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (1979) 1.24
Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci (2000) 1.24
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun (1993) 1.23
Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology (1989) 1.22
A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol (2006) 1.22
Surgery for benign insulinoma: an international review. World J Surg (1990) 1.21
Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci (1980) 1.20
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology (2005) 1.18
Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) (1990) 1.17
Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease. Nat Med (1995) 1.13
Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol (2000) 1.13
Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2. AJNR Am J Neuroradiol (2007) 1.11
Familial schizencephaly associated with EMX2 mutation. Neurology (1997) 1.09
Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci U S A (1992) 1.09
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol (2000) 1.09
Meningiomas of the lateral ventricles. Neuroradiological and surgical considerations in 18 cases. J Neurosurg (1981) 1.08
CT and MR imaging of neuroaxonal leukodystrophy presenting as early-onset frontal dementia. AJNR Am J Neuroradiol (2006) 1.07
Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J Biol Chem (1994) 1.07
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol (1999) 1.07
Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program. Transpl Infect Dis (2006) 1.07
Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol (2001) 1.07
Iatrogenic intracranial pseudoaneurysms: neuroradiological and therapeutical considerations, including endovascular options. Neurol Sci (2006) 1.07
Gasless laparoscopy. Surg Endosc (1999) 1.05
Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred). J Neuropathol Exp Neurol (1996) 1.04
Prostatic abscess drainage: clinical-sonography correlation. Urol Int (1992) 1.03
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. J Clin Oncol (2005) 1.03
Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology (1996) 1.02
Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol (2009) 1.02
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency. J Med Genet (2005) 1.01
Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest (1990) 1.01
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene. Neurology (2000) 1.01
Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol (1994) 1.01
A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun (1992) 1.00
Non-accidental brain trauma in infants: diffusion imaging, contributions to understanding the injury process. J Neuroradiol (2007) 1.00
Leprechaunism with mosaicism 46, XX/47, XX extra ring chromosome. J Med Genet (1977) 0.99
Syringomyelia associated with postmeningitic spinal arachnoiditis. Filling of the syrinx through a communication with the subarachnoid space. Neurology (1976) 0.98
Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem J (1999) 0.98
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur J Neurosci (1994) 0.97
A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Brain Res (1993) 0.97
Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol (1998) 0.97
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol (1995) 0.97
Spectral properties of EEG fast activity ictal discharges associated with infantile spasms. Clin Neurophysiol (1999) 0.96
Tauopathy in human and experimental variant Creutzfeldt-Jakob disease. Neurobiol Aging (2007) 0.96
Headache and intracranial hypotension: neuroradiological findings. Neurol Sci (2004) 0.96
Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease. Arch Neurol (1993) 0.96
Alzheimer patients and Down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci Lett (1990) 0.96
Gamma-ray bursts: huge explosion in the early Universe. Nature (2006) 0.96
Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J Neurosci Res (1998) 0.96
Magnetic resonance signal abnormalities along the pyramidal tracts in amyotrophic lateral sclerosis. Ital J Neurol Sci (1995) 0.95
Beta PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol (1993) 0.95
Intracranial cavernous hemangiomas: neuroradiologic review of 36 operated cases. AJNR Am J Neuroradiol (1983) 0.95
An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Am J Pathol (1998) 0.93
Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol (2008) 0.93
Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology (2001) 0.93
Neurofibrillary tangles of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease share antigenic determinants with those of Alzheimer disease. Brain Res (1990) 0.93